Trial Profile
A Prospective Double-Blind, Randomized Clinical Trial of Levocarnitine to Treat Autism Spectrum Disorders.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2011
Price :
$35
*
At a glance
- Drugs Levocarnitine (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 30 Mar 2010 New trial record